What is ACHIEVE?

No one should die from cervical cancer, as 93% of cervical cancer is preventable given effective HPV vaccination and early detection strategies. Yet, over 4,000 women die each year in the United States, particularly women from marginalized groups such as Hispanic/Latinx and non-Hispanic Black (NHB) women. Compared to non-Hispanic White (NHW) women, Hispanic/Latinx and non-Hispanic Black (NHB) women had the highest incidence and mortality rates of cervical cancer in 2020. These disparities are due to the impacts of structural racism across the care continuum.  

 

Thus, The ACHIEVE (Assessing Cervical Cancer Healthcare Inequities in Diverse Populations) Study will investigate the contribution of structural racism to inequities in cervical cancer treatment and survival. 

 

This project is a collaboration between The Columbia University Mailman School of Public Health (MSPH), The University of Southern California (USC) Keck School of Medicine, the Los Angeles County Cancer Surveillance Program (LACSP), and the New Jersey State Cancer Registry (NJSCR) managed by the Rutgers Cancer Institute (RCI).

​

​

The NJSCR is funded by the National Cancer Institute’s Surveillance, Epidemiology and End Results (SEER) Program (#75N91021D00009), Centers for Disease Control and Prevention’s National Program of Cancer Registries (#NU58DP007117) with additional support from the State of New Jersey and the Rutgers Cancer Institute.  The LACSP is supported by the National Cancer Institute's Surveillance, Epidemiology and End Results Program (HHSN261201800015I) and the Centers for Disease Control and Prevention's (CDC) National Program of Cancer Registries (5NU58DP006344).